Hale Plus Hearty

DNA nanorobots target HER2-positive breast cancer cells

According to the Mayo Clinic, about 20% of breast cancers make abnormally high levels of a protein called human epidermal

If a tumour is made up of cells with many different genomes, a single drug might not kill them all.

A new way to cleanly separate out cancer cells from a blood sample enables comprehensive genetic profiling of the cancer

According to researchers at Yale Cancer Center, a cancer drug thought to be of limited use possesses a superpower of sorts:

Mac, an 8-year-old boxer, lay sedated on a table in the gleaming new radiation treatment room at the Hixson-Lied Small Animal

In a new study, Yale Cancer Center scientists have demonstrated a powerful method to analyze how tumor cells are altered as they

A breast cancer cell is like a house with three locks on the front door. Keys, or receptors, allow drugs

Researchers have developed a computational model for human MEK1, a protein with potential as a drug target for a variety

A prototype wearable device, tested in animal models, can continuously collect live cancer cells directly from a patient’s blood. Developed

Immunotherapy, using the body’s own immune system to target and destroy cancer cells, is one of the most promising frontiers